Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
基本信息
- 批准号:8848342
- 负责人:
- 金额:$ 46.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-15 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAnti-Bacterial AgentsAntigen ReceptorsAtherosclerosisAttenuatedB-LymphocytesBacteriaBacterial InfectionsBindingBone MarrowCellsComplementCoupledCytoplasmic GranulesDataDiabetes MellitusDiseaseEffectivenessEventG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGoalsGrowthHealthHost DefenseITAMImmuneImmune System DiseasesImmune systemImmunityInfectionIntegrinsKnowledgeLCP2 geneLeadLigandsLupusMediatingMethodsMolecularMouse StrainsMovementMusNatural ImmunityOutcomePathologyPathway interactionsPhagocytosisPhosphorylationPlayProtein Tyrosine PhosphataseProtein-Serine-Threonine KinasesProteinsReactive Oxygen SpeciesReceptor SignalingRecruitment ActivityRegulationResearchRoleSignal PathwaySignal TransductionSignal Transduction PathwaySignaling ProteinSiteSpleenSyndromeSystemT-LymphocyteTestingThrombusTissuesVirulenceVirulence FactorsWorkYersiniaYersinia yopH proteinantimicrobialbactericidebasecell injurycell typecytokineextracellularinsightkillingsmutantneutrophilnovelparalogous genepathogenreceptorreceptor couplingresponse
项目摘要
DESCRIPTION (provided by applicant): Neutrophils (PMNs) are powerful anti-microbial cells that are rapidly mobilized and recruited to infected tissues and sites of tissue damage. Once within tissues, PMNs can deploy many activities to remove pathogens and/or damaged cells. Dysregulation of these events can have severe consequences for the host and contribute to the pathology a variety of diseases, including diabetes, thrombus formation and lupus. It has been increasingly recognized that immune cells generate appropriate responses by integrating a variety signals from receptors through multi-protein platforms, called microclusters. This signal integration has been studied extensively in T cells, but the specific rules of integration and cellular outcomes for one cell type do not necessarily apply to other cells because each cell type plays distinct roles in immunity. How PMNs integrate signals from the host and bacteria to generate the correct response in infected tissues is very poorly understood. This application seeks to uncover and understand critical molecular mechanisms PMNs employ to trigger bactericidal responses, using the bacterial pathogen, Yersinia, and its effector proteins, YopH and YopO. Based on our preliminary data indicating that YopH disrupts integration of signals by inactivating SKAP-2, PRAM-1 and SLP- 76-regulated pathways that emanate from micro-clusters, we will focus on understanding the role of SKAP2 in PMN responses. Our central hypothesis is that YopH and YopO impair PMN responses to bacteria by modulating a SKAP2-dependent system that coordinates the anti-microbial functions of PMNs triggered a variety of different types of receptors. Our aims are (1) to determine the critical functions of YopH in tissu infection; (2) dissect the role of SKAP2 in the anti-microbial responses of PMNs; and (3) understand the effects of YopO on neutrophil signaling after receptor stimulation. Through the proposed research, we expect to contribute a better understanding of the molecular mechanisms critical for PMNs anti-microbial responses. An understanding of how PMNs are inactivated by Yops in infected tissues will reveal the mechanisms by which PMNs deploy their anti-microbial and tissue damaging arsenal and lead to new ways to stop this deployment in auto-immune syndromes.
描述(由申请人提供):中性粒细胞(PMN)是强大的抗微生物细胞,可以快速动员并募集到受感染的组织和组织损伤部位。一旦进入组织,中性粒细胞就可以发挥许多作用来清除病原体和/或受损细胞。这些事件的失调会对宿主产生严重后果,并导致多种疾病的病理学,包括糖尿病、血栓形成和狼疮。人们越来越认识到,免疫细胞通过多蛋白平台(称为微簇)整合来自受体的各种信号来产生适当的反应。这种信号整合已在 T 细胞中得到广泛研究,但一种细胞类型的整合特定规则和细胞结果不一定适用于其他细胞,因为每种细胞类型在免疫中发挥着不同的作用。人们对中性粒细胞如何整合来自宿主和细菌的信号以在受感染组织中产生正确的反应知之甚少。该应用旨在利用细菌病原体耶尔森氏菌及其效应蛋白 YopH 和 YopO 来揭示和理解 PMN 用于触发杀菌反应的关键分子机制。我们的初步数据表明 YopH 通过失活微簇发出的 SKAP-2、PRAM-1 和 SLP-76 调节途径来破坏信号整合,我们将重点了解 SKAP2 在 PMN 反应中的作用。我们的中心假设是 YopH 和 YopO 通过调节 SKAP2 依赖性系统来损害 PMN 对细菌的反应,该系统协调 PMN 的抗微生物功能,触发各种不同类型的受体。我们的目标是 (1) 确定 YopH 在组织感染中的关键功能; (2)剖析SKAP2在PMNs抗微生物反应中的作用; (3) 了解 YopO 对受体刺激后中性粒细胞信号传导的影响。通过拟议的研究,我们希望能够更好地理解中性粒细胞抗微生物反应的关键分子机制。了解 PMN 如何在受感染组织中被 Yops 灭活,将揭示 PMN 部署其抗菌和组织损伤库的机制,并找到在自身免疫综合征中阻止这种部署的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joan C Mecsas其他文献
Joan C Mecsas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joan C Mecsas', 18)}}的其他基金
Dissecting Yersinia Yop Targets in Neutrophils
解析中性粒细胞中的耶尔森氏菌 Yop 靶标
- 批准号:
10570181 - 财政年份:2022
- 资助金额:
$ 46.74万 - 项目类别:
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
- 批准号:
9533472 - 财政年份:2017
- 资助金额:
$ 46.74万 - 项目类别:
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
- 批准号:
9222476 - 财政年份:2017
- 资助金额:
$ 46.74万 - 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
- 批准号:
9335269 - 财政年份:2016
- 资助金额:
$ 46.74万 - 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
- 批准号:
9046046 - 财政年份:2016
- 资助金额:
$ 46.74万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
8764810 - 财政年份:2014
- 资助金额:
$ 46.74万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
9258385 - 财政年份:2014
- 资助金额:
$ 46.74万 - 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
- 批准号:
9055639 - 财政年份:2014
- 资助金额:
$ 46.74万 - 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
- 批准号:
7839596 - 财政年份:2009
- 资助金额:
$ 46.74万 - 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
- 批准号:
7681382 - 财政年份:2008
- 资助金额:
$ 46.74万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 46.74万 - 项目类别:
Establishment of a Cell-Based Screening Platform for DNA Encoded Libraries
DNA编码文库细胞筛选平台的建立
- 批准号:
10646635 - 财政年份:2023
- 资助金额:
$ 46.74万 - 项目类别:
Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
- 批准号:
10651432 - 财政年份:2023
- 资助金额:
$ 46.74万 - 项目类别:
Targeting bacterial cell division with small molecules and peptides
用小分子和肽靶向细菌细胞分裂
- 批准号:
10510080 - 财政年份:2022
- 资助金额:
$ 46.74万 - 项目类别:
Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa
铜绿假单胞菌群体感应进展机制的表征
- 批准号:
10726940 - 财政年份:2022
- 资助金额:
$ 46.74万 - 项目类别: